Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 13.8
(0.73%)
CNY 13.8
(0.73%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.06 Billion CNY | 68.45% |
| 2022 | 982.55 Million CNY | 11.13% |
| 2021 | 884.15 Million CNY | 13.12% |
| 2020 | 781.63 Million CNY | 7.3% |
| 2019 | 728.47 Million CNY | 11.41% |
| 2018 | 653.86 Million CNY | -4.92% |
| 2017 | 687.71 Million CNY | 3.44% |
| 2016 | 664.84 Million CNY | 11.8% |
| 2015 | 594.69 Million CNY | 7.82% |
| 2014 | 551.59 Million CNY | -6.56% |
| 2013 | 590.34 Million CNY | 9.89% |
| 2012 | 537.22 Million CNY | 9.23% |
| 2011 | 491.84 Million CNY | 19.36% |
| 2010 | 412.06 Million CNY | -14.41% |
| 2009 | 481.43 Million CNY | 20.98% |
| 2008 | 397.94 Million CNY | 12.14% |
| 2007 | 354.87 Million CNY | 7.56% |
| 2006 | 329.93 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 216.61 Million CNY | -2.95% |
| 2024 Q3 | 276.83 Million CNY | 24.85% |
| 2024 Q1 | 223.19 Million CNY | -55.48% |
| 2023 FY | 1.65 Billion CNY | 68.45% |
| 2023 Q4 | 501.29 Million CNY | 78.74% |
| 2023 Q1 | 307.45 Million CNY | -8.24% |
| 2023 Q2 | 125.05 Million CNY | -59.33% |
| 2023 Q3 | 280.46 Million CNY | 124.28% |
| 2022 Q4 | 335.05 Million CNY | 16.78% |
| 2022 Q3 | 286.9 Million CNY | 114.71% |
| 2022 Q2 | 133.62 Million CNY | -41.13% |
| 2022 Q1 | 226.96 Million CNY | -31.54% |
| 2022 FY | 982.55 Million CNY | 11.13% |
| 2021 Q3 | 213.99 Million CNY | 34.33% |
| 2021 Q1 | 179.33 Million CNY | -47.65% |
| 2021 Q2 | 159.3 Million CNY | -11.17% |
| 2021 FY | 884.15 Million CNY | 13.12% |
| 2021 Q4 | 331.52 Million CNY | 54.92% |
| 2020 Q3 | 178.82 Million CNY | 27.97% |
| 2020 Q1 | 120.5 Million CNY | -60.63% |
| 2020 FY | 781.63 Million CNY | 7.3% |
| 2020 Q4 | 342.57 Million CNY | 91.57% |
| 2020 Q2 | 139.73 Million CNY | 15.96% |
| 2019 Q1 | 168.7 Million CNY | -32.5% |
| 2019 FY | 728.47 Million CNY | 11.41% |
| 2019 Q4 | 306.08 Million CNY | 80.08% |
| 2019 Q3 | 169.97 Million CNY | 103.03% |
| 2019 Q2 | 83.71 Million CNY | -50.38% |
| 2018 FY | 653.86 Million CNY | -4.92% |
| 2018 Q4 | 249.91 Million CNY | 78.79% |
| 2018 Q3 | 139.78 Million CNY | 28.41% |
| 2018 Q2 | 108.85 Million CNY | -29.91% |
| 2018 Q1 | 155.31 Million CNY | -44.02% |
| 2017 Q3 | 157.83 Million CNY | 61.09% |
| 2017 Q1 | 154.47 Million CNY | -46.44% |
| 2017 FY | 687.71 Million CNY | 3.44% |
| 2017 Q4 | 277.43 Million CNY | 75.78% |
| 2017 Q2 | 97.97 Million CNY | -36.57% |
| 2016 Q3 | 148.55 Million CNY | 67.92% |
| 2016 FY | 664.84 Million CNY | 11.8% |
| 2016 Q4 | 288.44 Million CNY | 94.17% |
| 2016 Q1 | 135.9 Million CNY | -47.68% |
| 2016 Q2 | 88.46 Million CNY | -34.91% |
| 2015 Q2 | 102.8 Million CNY | -2.06% |
| 2015 Q4 | 259.76 Million CNY | 104.28% |
| 2015 FY | 594.69 Million CNY | 7.82% |
| 2015 Q1 | 104.96 Million CNY | -44.27% |
| 2015 Q3 | 127.16 Million CNY | 23.7% |
| 2014 Q2 | 76.16 Million CNY | -45.03% |
| 2014 FY | 551.59 Million CNY | -6.56% |
| 2014 Q4 | 188.35 Million CNY | 26.83% |
| 2014 Q3 | 148.51 Million CNY | 94.99% |
| 2014 Q1 | 138.55 Million CNY | -35.29% |
| 2013 Q4 | 214.12 Million CNY | 39.19% |
| 2013 FY | 590.34 Million CNY | 9.89% |
| 2013 Q1 | 171.04 Million CNY | -21.36% |
| 2013 Q2 | 51.35 Million CNY | -69.97% |
| 2013 Q3 | 153.82 Million CNY | 199.53% |
| 2012 Q2 | 56.72 Million CNY | -51.09% |
| 2012 FY | 537.22 Million CNY | 9.23% |
| 2012 Q4 | 217.5 Million CNY | 47.94% |
| 2012 Q1 | 115.97 Million CNY | -39.42% |
| 2012 Q3 | 147.02 Million CNY | 159.2% |
| 2011 Q3 | 135.93 Million CNY | 107.68% |
| 2011 Q1 | 99 Million CNY | -42.0% |
| 2011 Q2 | 65.45 Million CNY | -33.89% |
| 2011 FY | 491.84 Million CNY | 19.36% |
| 2011 Q4 | 191.44 Million CNY | 40.84% |
| 2010 Q4 | 170.68 Million CNY | 83.4% |
| 2010 Q3 | 93.06 Million CNY | 103.29% |
| 2010 FY | 412.06 Million CNY | -14.41% |
| 2010 Q1 | 102.53 Million CNY | -51.09% |
| 2010 Q2 | 45.78 Million CNY | -55.35% |
| 2009 Q4 | 209.63 Million CNY | 98.17% |
| 2009 Q3 | 105.78 Million CNY | 21.02% |
| 2009 Q2 | 87.41 Million CNY | 11.22% |
| 2009 FY | 481.43 Million CNY | 20.98% |
| 2009 Q1 | 78.59 Million CNY | -52.28% |
| 2008 Q3 | 88.2 Million CNY | 0.0% |
| 2008 Q4 | 164.68 Million CNY | 86.71% |
| 2008 FY | 397.94 Million CNY | 12.14% |
| 2007 FY | 354.87 Million CNY | 7.56% |
| 2006 FY | 329.93 Million CNY | 0.0% |